Skip to main content
Caplight Logo









Denovo Sciences

Denovo Sciences

Private
YerevanHealthcare & Life Scienceshttps://denovosciences.ai/

Last Round

Strategic

May 5, 2025

Total Funding Raised

$1.3M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Denovo Sciences is a healthcare technology systems company that has developed an AI-powered platform to optimize and advance the development of new therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

AI drug discoverysmall molecule discoveryde novo drug designdrug discovery platformgenerative chemistryreinforcement learningin silico drug designdata-poor targetsAIDDcomputational drug discoverymolecular simulationsADMET predictionsynthetic feasibilitybinding pocket identificationbiotech partnerships

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Denovo Sciences Comparables

Compare Denovo Sciences with similar companies based on industry and business-model similarity.

Denovo Sciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Genesis Molecular AI
85%
Kuano
83%
Terray Therapeutics
79%

Denovo Sciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicMay 5, 2025
Pre SeedMar 15, 2023
AcceleratorSep 27, 2022

Denovo Sciences Investors

Notable investors and investment history

Denovo Sciences investors
InvestorRounds
Granatus VenturesAccelerator
Triple S VenturesStrategic, Pre Seed
Berkeley SkyDeckAccelerator
Alchemist AcceleratorStrategic
SASTiC ProgrammePre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2026

    Open roles increased to 4, 2.3x the trailing average.

  • Aug 22, 2026

    Monthly visitors grew 38% MoM, reaching 1.3K.

Denovo Sciences Filings

Explore SEC and related filing metadata, where available.

Denovo Sciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Denovo Sciences's valuation, stock price, and market status.

Is Denovo Sciences a public or private company?

Denovo Sciences is a private company.

What is the current stock price of Denovo Sciences?

Denovo Sciences is a private company with no public stock price. No recent secondary market data is available.

How much is Denovo Sciences worth (valuation)?

Valuation information for Denovo Sciences is not publicly available.

Can I buy Denovo Sciences stock?

Denovo Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Denovo Sciences's last funding round?

Denovo Sciences's most recent funding round was Strategic on May 5, 2025.

Who are the main investors in Denovo Sciences?

Key investors in Denovo Sciences include Triple S Ventures, Alchemist Accelerator.

Will Denovo Sciences IPO soon?

No public IPO plans have been announced for Denovo Sciences.

How can I track Denovo Sciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Denovo Sciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersYerevan
Employee Range17
Year Founded2019
Last FundingMay 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?